Summary of Anticholinergic Pharmacotherapy Available for Overactive Bladder Dysfunction

被引:0
|
作者
Mangera, Altaf [1 ]
Chapple, Christopher R. [2 ]
机构
[1] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Trust, Dept Urol Res, Sheffield, S Yorkshire, England
[2] Sheffield Hallam Univ, Royal Hallamshire Hosp, Room H26,H-Floor,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England
关键词
Overactive bladder syndrome; Anticholinergic therapy; Oxybutynin; Solifenacin; Tolterodine; Fesoterodine; Darifenacin; Propiverine; Trospium;
D O I
10.1007/s11884-011-0114-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bladder over activity affects many individuals worldwide. Anticholinergic therapy has become standard first-line pharmacotherapy for overactive bladder dysfunction after failure of conservative measures. Several different anticholinergic agents are currently utilized in clinical practice. In this article, we review the mechanism of action of these drugs. This review aims to summarize the contemporary evidence base behind the use of these agents in terms of efficacy, safety, and patient satisfaction. Anticholinergic agents lead to improvements in symptoms of urgency, frequency, and urgency incontinence; however, there are associated side effects related to dry mouth, pruritus, constipation, and the central nervous system.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [41] Trospilim chloride (Sanctura):: Another anticholinergic for overactive bladder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2004, 46 (1188): : 63 - 64
  • [42] Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
    Araklitis, George
    Robinson, Dudley
    Cardozo, Linda
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 1493 - 1503
  • [43] Which anticholinergic drug for overactive bladder symptoms in adults
    Madhuvrata, Priya
    Cody, June D.
    Ellis, Gaye
    Herbison, G. Peter
    Hay-Smith, E. Jean C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
  • [44] The Association between Anticholinergic Medications for Overactive Bladder and Pneumonia
    MacNeily, Zoe
    McArthur, Eric
    Ryerson, Christopher J.
    Welk, Blayne
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (09) : 1605 - 1609
  • [45] Improving the tolerability of anticholinergic agents in the treatment of overactive bladder
    Dmochowski, R
    DRUG SAFETY, 2005, 28 (07) : 583 - 600
  • [46] Double Anticholinergic Therapy for Refractory Overactive Bladder COMMENT
    Yang, Stephen Shei-Dei
    JOURNAL OF UROLOGY, 2009, 182 (04): : 2038 - 2039
  • [47] Double Anticholinergic Therapy for Refractory Overactive Bladder REPLY
    不详
    JOURNAL OF UROLOGY, 2009, 182 (04): : 2039 - 2039
  • [48] LONG-TERM DEMENTIA RISK WITH USE OF ANTICHOLINERGIC VERSUS BETA-3-AGONIST PHARMACOTHERAPY FOR OVERACTIVE BLADDER
    Sheyn, David
    Gupta, Ankita
    Rhodes, Stephen
    Murphy, Jennifer
    Perez, Jamie
    Scott, Lindsay
    Hijaz, Adonis
    Mahajan, Abhimanuy
    Bretschneider, Carol
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1143 - E1143
  • [49] NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
    Xie, Xiang
    Luo, Chuang
    Liang, Jia Yu
    Huang, Run
    Yang, Jia Li
    Li, Linlong
    Li, YangYang
    Xing, Hongming
    Chen, Huan
    PEERJ, 2021, 9